Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Wigley

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Current Opinion in Rheumatology|November 1, 1995
Treatment of sclerodermaA C Gelber, F M Wigley
Expert Opinion on Investigational Drugs|December 16, 2000
Novel therapy in the treatment of sclerodermaF M Wigley, S D Sule
Rheumatic Diseases Clinics of North America|November 1, 1996
Raynaud's phenomenonF M Wigley, N A Flavahan
Bulletin on the Rheumatic Diseases|April 5, 2001
Update on management of sclerodermaS D Sule, F M Wigley
Seminars in Cutaneous Medicine and Surgery|March 25, 1998
Management of systemic sclerosis: the art and scienceJ H Stone, F M Wigley
Drugs & Aging|September 30, 1999
Raynaud's phenomenon in older adults: diagnostic considerations and managementS M Ling, F M Wigley
The Journal of Rheumatology|August 1, 1987
Reproducibility of cold provocation in patients with Raynaud's phenomenonF M Wigley, R Malamet, R A Wise
Lancet (London, England)|February 19, 1999
A man with diabetes and a swollen legM Sagar, W M Bowerfind, F M Wigley
Angiology|September 1, 1985
Digital pressure-flow relationships in subjects with Raynaud's phenomenonR A Wise, F M Wigley, R Malamet
Journal of Clinical Epidemiology|April 1, 1995
Frequency of augmentation mammoplasty in patients with systemic sclerosis: data from the Johns Hopkins-University of Maryland Scleroderma CenterM C Hochberg, R Miller, F M Wigley
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Current Opinion in Rheumatology|November 1, 1995
Treatment of sclerodermaA C Gelber, F M Wigley
Expert Opinion on Investigational Drugs|December 16, 2000
Novel therapy in the treatment of sclerodermaF M Wigley, S D Sule
Rheumatic Diseases Clinics of North America|November 1, 1996
Raynaud's phenomenonF M Wigley, N A Flavahan
Bulletin on the Rheumatic Diseases|April 5, 2001
Update on management of sclerodermaS D Sule, F M Wigley
Seminars in Cutaneous Medicine and Surgery|March 25, 1998
Management of systemic sclerosis: the art and scienceJ H Stone, F M Wigley
Drugs & Aging|September 30, 1999
Raynaud's phenomenon in older adults: diagnostic considerations and managementS M Ling, F M Wigley
The Journal of Rheumatology|August 1, 1987
Reproducibility of cold provocation in patients with Raynaud's phenomenonF M Wigley, R Malamet, R A Wise
Lancet (London, England)|February 19, 1999
A man with diabetes and a swollen legM Sagar, W M Bowerfind, F M Wigley
Angiology|September 1, 1985
Digital pressure-flow relationships in subjects with Raynaud's phenomenonR A Wise, F M Wigley, R Malamet
Journal of Clinical Epidemiology|April 1, 1995
Frequency of augmentation mammoplasty in patients with systemic sclerosis: data from the Johns Hopkins-University of Maryland Scleroderma CenterM C Hochberg, R Miller, F M Wigley
Pageof 10